Literature DB >> 20430874

Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Folke Freudenberg1, Monika R Leonard, Shou-An Liu, Jonathan N Glickman, Martin C Carey.   

Abstract

Gallstones are frequent in patients with cystic fibrosis (CF). These stones are generally "black" pigment (i.e., Ca bilirubinate) with an appreciable cholesterol admixture. The pathophysiology and molecular mechanisms for this "mixed" gallstone in CF are unknown. Here we investigate in a CF mouse model with no overt liver or gallbladder disease whether pathophysiological changes in the physical chemistry of gallbladder bile might predict the occurrence of "mixed" cholelithiasis. Employing a DeltaF508 mouse model with documented increased fecal bile acid loss and induced enterohepatic cycling of bilirubin (Am J Physiol Gastrointest Liver Physiol 294: G1411-G1420, 2008), we assessed gallbladder bile chemistry, morphology, and microscopy in CF and wild-type mice, with focus on the concentrations and compositions of the common biliary lipids, bilirubins, Ca(2+), and pH. Our results demonstrate that gallbladder bile of CF mice contains significantly higher levels of all bilirubin conjugates and unconjugated bilirubin with lower gallbladder bile pH values. Significant elevations in Ca bilirubinate ion products in bile of CF mice increase the likelihood of supersaturating bile and forming black pigment gallstones. The risk of potential pigment cholelithogenesis is coupled with higher cholesterol saturations and bile salt hydrophobicity indexes, consistent with a proclivity to cholesterol phase separation during pigment gallstone formation. This is an initial step toward unraveling the molecular basis of CF gallstone disease and constitutes a framework for investigating animal models of CF with more severe biliary disease, as well as the human disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430874      PMCID: PMC2904121          DOI: 10.1152/ajpgi.00341.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  63 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Regulation of electrogenic anion secretion in normal and cystic fibrosis gallbladder mucosa.

Authors:  T Chinet; L Fouassier; N Dray-Charier; M Imam-Ghali; H Morel; M Mergey; B Dousset; R Parc; A Paul; C Housset
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

3.  Natural history of liver disease in cystic fibrosis.

Authors:  A Lindblad; H Glaumann; B Strandvik
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

Review 4.  Cholangiocyte biology and cystic fibrosis liver disease.

Authors:  A P Feranchak; R J Sokol
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

5.  Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.

Authors:  M A Brink; J F Slors; Y C Keulemans; K S Mok; D R De Waart; M C Carey; A K Groen; G N Tytgat
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.

Authors:  Q Chen; J Amaral; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

7.  A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

Authors:  P J French; J H van Doorninck; R H Peters; E Verbeek; N A Ameen; C R Marino; H R de Jonge; J Bijman; B J Scholte
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Bile acid kinetics and biliary lipid composition in cystic fibrosis.

Authors:  B Strandvik; K Einarsson; A Lindblad; B Angelin
Journal:  J Hepatol       Date:  1996-07       Impact factor: 25.083

Review 9.  Pathophysiology of gene-targeted mouse models for cystic fibrosis.

Authors:  B R Grubb; R C Boucher
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  Bilirubin induces loss of membrane lipids and exposure of phosphatidylserine in human erythrocytes.

Authors:  M A Brito; R F M Silva; D Brites
Journal:  Cell Biol Toxicol       Date:  2002       Impact factor: 6.691

View more
  6 in total

1.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

2.  Pancreatic and biliary secretion are both altered in cystic fibrosis pigs.

Authors:  Aliye Uc; Radhamma Giriyappa; David K Meyerholz; Michelle Griffin; Lynda S Ostedgaard; Xiao Xiao Tang; Marwa Abu-El-Haija; David A Stoltz; Paula Ludwig; Alejandro Pezzulo; Maisam Abu-El-Haija; Peter Taft; Michael J Welsh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

3.  Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous "black" pigment gallstone formation in germfree Swiss Webster mice.

Authors:  Stephanie E Woods; Monika R Leonard; Joshua A Hayden; Megan Brunjes Brophy; Kara R Bernert; Brigitte Lavoie; Sureshkumar Muthupalani; Mark T Whary; Gary M Mawe; Elizabeth M Nolan; Martin C Carey; James G Fox
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

Review 4.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

Review 5.  CFTR, mucins, and mucus obstruction in cystic fibrosis.

Authors:  Silvia M Kreda; C William Davis; Mary Callaghan Rose
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

6.  Cholic acid induces a Cftr dependent biliary secretion and liver growth response in mice.

Authors:  Frank A J A Bodewes; Marcel J Bijvelds; Willemien de Vries; Juul F W Baller; Annette S H Gouw; Hugo R de Jonge; Henkjan J Verkade
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.